Related Experiment Video

Updated: Jul 4, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Could IFN-gamma predict the development of residual pleural thickening in tuberculous pleurisy?

I Gerogianni1, M Papala, P Tsopa

  • 1Department of Respiratory Medicine, Medical School, University of Larissa, Larissa, Greece. igerogianni@yahoo.gr

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|May 30, 2008
PubMed
Abstract

Insights

Interferon-gamma (IFN-gamma) in pleural fluid may predict residual pleural thickening (RPT) in tuberculous pleurisy (TP). Higher IFN-gamma levels were observed in patients with significant RPT, suggesting its potential role in disease progression.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Radiology

Background:

  • Tuberculous pleurisy (TP) can lead to residual pleural thickening (RPT).
  • Identifying factors predicting RPT is crucial for managing TP complications.

Purpose of the Study:

  • To identify predictive factors for the development of residual pleural thickening (RPT) in patients with tuberculous pleurisy (TP).

Main Methods:

  • Retrospective study of patients diagnosed with pleural tuberculosis.
  • Analysis of clinical, radiological, microbiological, and biochemical markers, including adenosine deaminase (ADA), interferon-gamma (IFN-gamma), and vascular endothelial growth factor (VEGF) in pleural fluid.

Main Results:

  • Out of 31 patients, 80.6% developed RPT (> 2 mm), and 32.2% had RPT >= 10 mm.
  • Smaller pleural effusions were associated with a lower rate of pleural thickening (p<0.05).
  • Elevated pleural fluid IFN-gamma levels were significantly higher in patients with RPT >= 10 mm compared to those with RPT < 10 mm (p < 0.05).

Conclusions:

  • Pleural fluid IFN-gamma warrants further investigation as a potential biomarker for predicting RPT in TP.
  • Understanding IFN-gamma's role could inform preventive and therapeutic strategies for RPT and its clinical sequelae.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Physical Assessment of the Respiratory Tract II: Palpation01:24

Physical Assessment of the Respiratory Tract II: Palpation

Physical assessment of the respiratory tract is critical in identifying potential health issues. One key component of this assessment is palpation, a technique healthcare providers use to assess the body for abnormalities. This content explores the method of palpation in evaluating the respiratory tract, focusing on thoracic palpation and tactile fremitus.
Thoracic Palpation
Thoracic palpation detects tenderness, masses, lesions, respiratory excursions, and vocal fremitus. The nurse assesses...